THE INDUSTRY LEADER IN MEMBRANE PROTEIN SOLUTIONS

Integral Molecular launches spin-out company for validated reagent antibodies.
5/9/2024

Integral Molecular Launches Virus Neutralization Assay Services
4/16/2024

Integral Molecular Achieves ISO 9001 Certification for its Membrane Proteome Array Service
3/27/2024

BIO International
June 3rd-6th, 2024
San Diego, CA
 
Immuno-Oncology Summit
Aug 7th-9th, 2024
Philadelphia, PA
 
Disease Prevention and Control Summit
Sep 5th-6th, 2024
Philadelphia, PA
 

Breaking barriers in antibody discovery: Harnessing divergent species for accessing difficult and conserved targets
mAbs, 2023

Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes
Cell Reports, 2023

Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
Nature Communications, 2023

THE INDUSTRY LEADER IN MEMBRANE PROTEIN SOLUTIONS

Leading Expertise in Antibodies, Viruses & Membrane Proteins

Multi-spanning membrane proteins are targets of half of all small molecule drugs but only 3 therapeutic monoclonal antibodies (MAbs).

drug targets
Integral Molecular is built on innovation and driven to impact the scientific community and human health. We apply deep expertise in target biology, antibody discovery, virology, and protein engineering to advance therapies against difficult-to-treat diseases.

Transformative Technologies for Solving Scientific Challenges

Your research deserves a trusted ally. We are problem-solving enthusiasts ready with the right tools to tackle your biggest scientific challenges.

INDUSTRY EXPERIENCE

With 20+ years experience, Integral Molecular is the industry leader in isolating and characterizing complex membrane proteins.

PROVEN QUALITY

Integral Molecular’s technologies continuously contribute to scientific discoveries featured in peer-reviewed publications, including in top journals.

OPEN COMMUNICATION

Your success is our priority. We work
hard to understand your needs, and we
strive to exceed your expectations.

Products, Services & Partnering Opportunities

Antibody specificity screening for lead selection & IND safety profiling

Reporter Virus Particles and other tools to expedite vaccine and antibody development

Virus-like particles with the highest level of native membrane proteins for better immunization & screening
Delivering lead candidates through IND
Comprehensive Ala-scan epitope mapping service for mechanism-of-action data & stronger IP
High-throughput protein engineering services for improving MAbs, viruses, enzymes & more
Therapeutic antibody assets available for licensing

500+ Publications

Trusted by 600+ Companies

Integral Molecular partnership logos
logos-2019v2

Ready To Get Started?

We have worked with more than 100 top biotech and pharmaceutical companies to help them succeed. Let’s talk about how we can help you.